Fig. 3.

The distribution of the 72 subjects in this study with respect to metabolic abnormalities. Thirty-one subjects had no identifiable metabolic abnormalities (“Normal Metabolism”), while 41 had early abnormalities, prediabetes and/or clinically-defined metabolic syndrome (MetS). Twenty-five of the 41 met the ADA criteria for prediabetes, and 10 of those 25 also met the harmonized clinical criteria for MetS [4]. The remaining 16 subjects with “Early Abnormalities” were identified by low water T₂ values in the absence of prediabetes. Only three of those 16 met the clinical criteria for MetS. Thus, water T₂ uniquely identified 13 individuals with abnormalities consistent with early metabolic syndrome